Low-molecular weight molluscan glycosaminoglycan from bivalve Katelysia opima (Gmelin)

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 3, 2008, Pages 175-180

  Vijayabaskar, P ^a   Balasubramanian, T ^a   Somasundaram, S T ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Anticoagulant; Glycosaminoglycan; Gradient PAGE analysis; Katelysia opima; LMWH

Indexed keywords

CELLULOSE; DYE; GLYCOSAMINOGLYCAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NATURAL PRODUCT; NITROUS ACID;

ANTICOAGULATION; ARTICLE; BIVALVE; COLORIMETRY; DEPOLYMERIZATION; DRUG ACTIVITY; DRUG ISOLATION; DRUG PURIFICATION; DRUG PURITY; DRUG QUALITY; FRACTIONATION; INFRARED SPECTROSCOPY; KATELYSIA OPIMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRODUCT RECOVERY;

ANIMALS; ANTICOAGULANTS; BIVALVIA; GLYCOSAMINOGLYCANS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; INDIA; SHELLFISH;

EID: 48249113419     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.3.1159654     Document Type: Article

References (28)

1. Jaques, L.B. Heparin: An old drug with a new paradigm. Science 1979, 206: 528-33.
2. Linhardt, R.J., Gunay, N.S. Production and chemical processing of low molecular weight heparins. Sem Thrombos Hemostas 1999, 25: 5-16.
3. 1H NMR spectroscopical evidence for the maintenance of the structure through evolution. Int J Biol Macromol 1989, 11: 361-6.
4. Medeiros, G.F., Menden, A., Castro, R.A. et al. Distribution of sulfated glycosaminoglycans in the animal kingdom: Widespread occurrence of heparin-like compounds in invertebrates. Biochim Biophys Acta 2000, 1475: 287-94.
5. Mulloy, B. The specificity of interaction between proteins and sulfated polysaccharides. Anais da Acad Brasileira de Ciencias 2005, 77: 651-64.
6. Nader, H.B., Chavante, S.F., dos-Santos, E.A. et al. Heparan sulfates and heparins: Similar compounds performing the same functions in vertebrates and invertebrates? Braz J Med Biol Res 1989, 32(5): 529-38.
7. Freedman, M.D. Pharmacodynamics, clinical indications and adverse effects of heparin. J Clin Pharmacol 1992, 32: 584-96.
8. Rydberg J.E., Westfall, J.M., Nicholas, R.A. Low-molecular-weight heparin in preventing and treating DVT. Clin Pharmacol 1999, 59(6): 1-11.
9. Islam, T., Linhardt, R.J. Carbohydrate based drug discovery. In: Chemistry, Biochemistry and Pharmaceuticals Potentials of Glycosaminoglycans and Related Saccharides I. Chi-Huey Wong (Ed). Wiley-VCH, Weinheim 2003, 407-33.
10. Kim, Y.S., You, Y.J., Chang, I., Toidas, T.K. A new glycosaminoglycan from the giant African snail Achatina fulica. J Biol Chem 1996, 271(2): 11750-5.
11. Hirsch, J., Raschke, R., Warkentin, T.E., Daten, J.E., Deykin, D., Poller, L. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1995, 108(4): 258-75.
12. Nadkarni, D.V., Toshihiko T., Van Gorp, C.L. et al. Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives. Carbohydr Res 1996, 290: 87-96.
13. The United States of Pharmacopoeia and the National Formulary, 1995. Heparin sodium United States Pharmacopoeical Conventional Inc, Asian. Edition-USP 23-NF18, 736-738.
14. Holick, M.F., Judkiewicz, A., Walworth, N., Wang, M.H. Recovery of heparin from fish wastes. In: Biotechnology of Marine Polysaccharide. Cowell, R.R., Pariser, E.R., Sinskey, A.J. (Eds.). Hemisphere: New York 1985, 389-97.
15. Linhardt, J.R., Ampofo, S.A., Jawed, F., Hoppensteadt, D., Mulliken, J.B., Folkman, J. Isolation and characterization of human heparin. Am Chem Soc Biochem 1992, 31: 12441-5.
16. Pejiler, G., Danielsson, A., Bjork, I., Lindahl, U. Structure and antithrombin binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J Biol Chem 1987, 262(24): 11413-21.
17. Wladimir, R.L.F., Valente, A.-P., Pereira, M.S., Maurao, P.A.S. Structural and anticoagulant activity of sulfated galactans. J Biol Chem 2000, 275: 29299-307.
18. Shanmugam, M., Mody, K.H., Ramavat, B.K., Murthy, S.K., Siddhanta, A.K. Screening of codiacean algae (chlorophyta) of the Indian coasts for blood anticoagulant activity. Indian J Mar Sci 2001, 31(1): 33-8.
19. Pancake, S.J., Karnovsky, L.M. The isolation and characterization of a mucopolysaccharide secreted by the snail, Otella lactea. J Biol Chem 1971, 246: 253-62.
20. Mauro, S.G.P., Karin, R.M.A., Wernecie, C.C., Silva, L.C.F., Maurao, P.A.S. Highly sulfated dermatan sulfates from Ascidians. J Biol Chem 1998, 273(43): 27848-54.
21. Muruganantham, A. Heparin from seaweeds - A search in Grateloupia filicina (Wulf). J. Ag., Ph.D. Thesis, Annamalai University, Tamilnadu, India.
22. Hirsh, J., Shanghnessy, S.G., Halperin, J.L.Granger, C., Ohman, E.M., Dalen, J.E. Heparin and low-molecular-weight heparin. In: The 6th ACCP Consensus Conference on Antithrombotic Therapy, 2001. vol. 119, 65-94.
23. Linhardt, J.R., Loganathan, D., Al-Hakim, A., Hui-Ming, W., Walenga, J.M., Hoppensteadt, D. Oligosaccharide mapping of low molecular weight heparin: Structure and activity differences. J Med Chem 1990, 33: 1639-45.
24. Jesks, J.F., Hoppensteadt, D. Low-molecular-weight heparins: Pharmacology profile and product difference. Am J Cardiol 1998, 82: 31-101.
25. Burson, S.L., Fahrenbach, M.J., Frommhagen, L.H. et al. Isolation and purification of mactins, heparin like anti-coagulants from mollusca. J Am Chem Soc 1956, 78: 5874-9.
26. Yu, G., Huashi, G., Jiamin, X., Qun, W., Linhardt, R.J. Preparation and structural activity difference of low molecular weight heparin (LMWH). J Ocean Univ Qingdao 2001, 31(5): 673-80.
27. Mitragotri, S., Kost, J. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharmaceut Res 2001, 18(8): 1151-6.
28. Toida, T., Maruyyama, T., Ogita, Y., Suzuki, A., Linhardt, R.J. Preparation and anticoagulant activity of fully O-sulphated glycosaminoglycans. Int J Biol Macromol 1999, 26: 233-41.